nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—HRH3—attention deficit hyperactivity disorder	0.878	1	CbGaD
Azelastine—HRH3—forebrain—attention deficit hyperactivity disorder	0.00258	0.108	CbGeAlD
Azelastine—HRH3—nervous system—attention deficit hyperactivity disorder	0.0014	0.0588	CbGeAlD
Azelastine—HRH3—central nervous system—attention deficit hyperactivity disorder	0.00135	0.0566	CbGeAlD
Azelastine—HRH3—cerebellum—attention deficit hyperactivity disorder	0.00132	0.0554	CbGeAlD
Azelastine—HRH3—brain—attention deficit hyperactivity disorder	0.00107	0.045	CbGeAlD
Azelastine—Mazindol—SLC6A3—attention deficit hyperactivity disorder	0.000782	0.0996	CrCbGaD
Azelastine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000746	0.0313	CbGeAlD
Azelastine—KCNH2—forebrain—attention deficit hyperactivity disorder	0.000746	0.0313	CbGeAlD
Azelastine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000719	0.0302	CbGeAlD
Azelastine—Loxapine—DRD5—attention deficit hyperactivity disorder	0.000687	0.0875	CrCbGaD
Azelastine—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.000648	0.0825	CrCbGaD
Azelastine—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.000631	0.0265	CbGeAlD
Azelastine—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.000621	0.0261	CbGeAlD
Azelastine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000598	0.0251	CbGeAlD
Azelastine—Clozapine—HRH3—attention deficit hyperactivity disorder	0.000596	0.0759	CrCbGaD
Azelastine—Mazindol—SLC6A4—attention deficit hyperactivity disorder	0.000585	0.0745	CrCbGaD
Azelastine—ADRA1B—brain—attention deficit hyperactivity disorder	0.00057	0.0239	CbGeAlD
Azelastine—Clozapine—ADRA2C—attention deficit hyperactivity disorder	0.000544	0.0693	CrCbGaD
Azelastine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000518	0.0217	CbGeAlD
Azelastine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000513	0.0215	CbGeAlD
Azelastine—CYP2A6—brain—attention deficit hyperactivity disorder	0.000505	0.0212	CbGeAlD
Azelastine—KCNH2—midbrain—attention deficit hyperactivity disorder	0.000493	0.0207	CbGeAlD
Azelastine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000486	0.0204	CbGeAlD
Azelastine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000455	0.0191	CbGeAlD
Azelastine—KCNH2—nervous system—attention deficit hyperactivity disorder	0.000405	0.017	CbGeAlD
Azelastine—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.00039	0.0164	CbGeAlD
Azelastine—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.000381	0.016	CbGeAlD
Azelastine—Loxapine—DRD4—attention deficit hyperactivity disorder	0.000352	0.0448	CrCbGaD
Azelastine—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.000342	0.0144	CbGeAlD
Azelastine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000332	0.0139	CbGeAlD
Azelastine—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.000329	0.0138	CbGeAlD
Azelastine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000327	0.0137	CbGeAlD
Azelastine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000325	0.0136	CbGeAlD
Azelastine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00032	0.0134	CbGeAlD
Azelastine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000312	0.0131	CbGeAlD
Azelastine—Loxapine—HTR1B—attention deficit hyperactivity disorder	0.000312	0.0398	CrCbGaD
Azelastine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000312	0.0131	CbGeAlD
Azelastine—KCNH2—brain—attention deficit hyperactivity disorder	0.00031	0.013	CbGeAlD
Azelastine—Loxapine—DRD3—attention deficit hyperactivity disorder	0.000303	0.0386	CrCbGaD
Azelastine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.0003	0.0126	CbGeAlD
Azelastine—Loxapine—DRD1—attention deficit hyperactivity disorder	0.000298	0.0379	CrCbGaD
Azelastine—Clozapine—DRD4—attention deficit hyperactivity disorder	0.000295	0.0376	CrCbGaD
Azelastine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000294	0.0123	CbGeAlD
Azelastine—CYP2C8—brain—attention deficit hyperactivity disorder	0.000283	0.0119	CbGeAlD
Azelastine—Loxapine—SLC6A3—attention deficit hyperactivity disorder	0.000282	0.0359	CrCbGaD
Azelastine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000277	0.0116	CbGeAlD
Azelastine—Loxapine—ADRA2A—attention deficit hyperactivity disorder	0.000277	0.0352	CrCbGaD
Azelastine—Clozapine—HTR1B—attention deficit hyperactivity disorder	0.000262	0.0334	CrCbGaD
Azelastine—CYP1A1—brain—attention deficit hyperactivity disorder	0.000261	0.011	CbGeAlD
Azelastine—Clozapine—DRD3—attention deficit hyperactivity disorder	0.000255	0.0324	CrCbGaD
Azelastine—CYP2B6—brain—attention deficit hyperactivity disorder	0.000254	0.0107	CbGeAlD
Azelastine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000251	0.0105	CbGeAlD
Azelastine—Clozapine—DRD1—attention deficit hyperactivity disorder	0.00025	0.0318	CrCbGaD
Azelastine—HRH1—brain—attention deficit hyperactivity disorder	0.000248	0.0104	CbGeAlD
Azelastine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000247	0.0104	CbGeAlD
Azelastine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000242	0.0101	CbGeAlD
Azelastine—CYP2E1—brain—attention deficit hyperactivity disorder	0.000238	0.01	CbGeAlD
Azelastine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000238	0.00998	CbGeAlD
Azelastine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000232	0.00975	CbGeAlD
Azelastine—Clozapine—ADRA2A—attention deficit hyperactivity disorder	0.000232	0.0296	CrCbGaD
Azelastine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000216	0.00907	CbGeAlD
Azelastine—Loxapine—SLC6A4—attention deficit hyperactivity disorder	0.000211	0.0269	CrCbGaD
Azelastine—Loxapine—DRD2—attention deficit hyperactivity disorder	0.00021	0.0267	CrCbGaD
Azelastine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000189	0.00792	CbGeAlD
Azelastine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000178	0.00746	CbGeAlD
Azelastine—Clozapine—DRD2—attention deficit hyperactivity disorder	0.000176	0.0224	CrCbGaD
Azelastine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000171	0.00718	CbGeAlD
Azelastine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000167	0.00702	CbGeAlD
Azelastine—Loxapine—HTR2A—attention deficit hyperactivity disorder	0.000162	0.0206	CrCbGaD
Azelastine—Clozapine—HTR2A—attention deficit hyperactivity disorder	0.000136	0.0173	CrCbGaD
Azelastine—ABCB1—brain—attention deficit hyperactivity disorder	0.000136	0.0057	CbGeAlD
Azelastine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	7.96e-05	0.000882	CbGpPWpGaD
Azelastine—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.93e-05	0.000879	CbGpPWpGaD
Azelastine—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.88e-05	0.000873	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.85e-05	0.00087	CbGpPWpGaD
Azelastine—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.82e-05	0.000867	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.72e-05	0.000856	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.56e-05	0.000838	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.54e-05	0.000836	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	7.42e-05	0.000823	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.34e-05	0.000814	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.3e-05	0.000809	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.17e-05	0.000795	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.16e-05	0.000794	CbGpPWpGaD
Azelastine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.09e-05	0.000786	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.09e-05	0.000786	CbGpPWpGaD
Azelastine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.08e-05	0.000785	CbGpPWpGaD
Azelastine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.03e-05	0.000779	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.01e-05	0.000777	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.99e-05	0.000775	CbGpPWpGaD
Azelastine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.98e-05	0.000774	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.87e-05	0.000761	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.85e-05	0.000759	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.82e-05	0.000756	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	6.8e-05	0.000753	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	6.8e-05	0.000753	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.73e-05	0.000747	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.61e-05	0.000733	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.6e-05	0.000732	CbGpPWpGaD
Azelastine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.51e-05	0.000722	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.5e-05	0.000721	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.49e-05	0.00072	CbGpPWpGaD
Azelastine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.47e-05	0.000717	CbGpPWpGaD
Azelastine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.46e-05	0.000716	CbGpPWpGaD
Azelastine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.42e-05	0.000712	CbGpPWpGaD
Azelastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.41e-05	0.000711	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.41e-05	0.000711	CbGpPWpGaD
Azelastine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.41e-05	0.000711	CbGpPWpGaD
Azelastine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	6.38e-05	0.000707	CbGpPWpGaD
Azelastine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.37e-05	0.000706	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.34e-05	0.000703	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.26e-05	0.000694	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.22e-05	0.000689	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.17e-05	0.000684	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	6.09e-05	0.000675	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.07e-05	0.000673	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.06e-05	0.000672	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.98e-05	0.000662	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.96e-05	0.000661	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.89e-05	0.000653	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.59e-05	0.00062	CbGpPWpGaD
Azelastine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.52e-05	0.000612	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.5e-05	0.000609	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.48e-05	0.000608	CbGpPWpGaD
Azelastine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.48e-05	0.000607	CbGpPWpGaD
Azelastine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.44e-05	0.000603	CbGpPWpGaD
Azelastine—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	5.31e-05	0.000588	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.24e-05	0.000581	CbGpPWpGaD
Azelastine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	5.19e-05	0.000576	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.82e-05	0.000534	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.76e-05	0.000528	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.75e-05	0.000526	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.74e-05	0.000526	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.62e-05	0.000513	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.58e-05	0.000508	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.36e-05	0.000484	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.31e-05	0.000478	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.26e-05	0.000472	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.26e-05	0.000472	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.23e-05	0.000469	CbGpPWpGaD
Azelastine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.2e-05	0.000466	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.19e-05	0.000464	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.16e-05	0.000461	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.15e-05	0.00046	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.14e-05	0.000459	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.13e-05	0.000457	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.06e-05	0.00045	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.05e-05	0.00045	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4e-05	0.000444	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.98e-05	0.000441	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.87e-05	0.000429	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.86e-05	0.000427	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.84e-05	0.000426	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.83e-05	0.000425	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.77e-05	0.000418	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.75e-05	0.000416	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.75e-05	0.000416	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.75e-05	0.000415	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.75e-05	0.000415	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.73e-05	0.000414	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.73e-05	0.000414	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.68e-05	0.000408	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.67e-05	0.000407	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.67e-05	0.000407	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.64e-05	0.000403	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.62e-05	0.000402	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.6e-05	0.000399	CbGpPWpGaD
Azelastine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	3.58e-05	0.000397	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.54e-05	0.000392	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.5e-05	0.000388	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.39e-05	0.000376	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.39e-05	0.000376	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.38e-05	0.000374	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.00037	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.29e-05	0.000365	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	3.28e-05	0.000363	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.28e-05	0.000363	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.24e-05	0.00036	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.22e-05	0.000358	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.07e-05	0.00034	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3e-05	0.000332	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.97e-05	0.000329	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.9e-05	0.000321	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.83e-05	0.000313	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.81e-05	0.000312	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.73e-05	0.000302	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.66e-05	0.000295	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.64e-05	0.000293	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.64e-05	0.000293	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.64e-05	0.000293	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.62e-05	0.000291	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.61e-05	0.00029	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.6e-05	0.000288	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.59e-05	0.000287	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.59e-05	0.000287	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	2.59e-05	0.000287	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.59e-05	0.000287	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.55e-05	0.000283	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.55e-05	0.000282	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	2.54e-05	0.000282	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.49e-05	0.000277	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.46e-05	0.000272	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.44e-05	0.000271	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.44e-05	0.000271	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.42e-05	0.000268	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.4e-05	0.000266	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.37e-05	0.000263	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.37e-05	0.000263	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.37e-05	0.000262	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.36e-05	0.000262	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.28e-05	0.000253	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.26e-05	0.00025	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	2.24e-05	0.000248	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.24e-05	0.000248	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.23e-05	0.000248	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.22e-05	0.000247	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.21e-05	0.000245	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	2.2e-05	0.000244	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.18e-05	0.000241	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.15e-05	0.000238	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.15e-05	0.000238	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.11e-05	0.000234	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.07e-05	0.00023	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.07e-05	0.000229	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.07e-05	0.000229	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.05e-05	0.000227	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.03e-05	0.000226	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.01e-05	0.000223	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2e-05	0.000222	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2e-05	0.000222	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	2e-05	0.000222	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	2e-05	0.000222	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	1.99e-05	0.00022	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.97e-05	0.000219	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.97e-05	0.000219	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.97e-05	0.000218	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.97e-05	0.000218	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.97e-05	0.000218	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.95e-05	0.000216	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.95e-05	0.000216	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.95e-05	0.000216	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.94e-05	0.000216	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.92e-05	0.000213	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.86e-05	0.000206	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.84e-05	0.000204	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.84e-05	0.000204	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.83e-05	0.000203	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	1.82e-05	0.000202	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.82e-05	0.000202	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.81e-05	0.000201	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.81e-05	0.0002	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.79e-05	0.000199	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.79e-05	0.000198	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.78e-05	0.000198	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.74e-05	0.000193	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.7e-05	0.000189	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.68e-05	0.000186	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.67e-05	0.000185	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	1.6e-05	0.000178	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.6e-05	0.000177	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.59e-05	0.000176	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	1.57e-05	0.000174	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	1.57e-05	0.000174	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.56e-05	0.000173	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.56e-05	0.000173	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.56e-05	0.000173	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.56e-05	0.000173	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	1.56e-05	0.000172	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.53e-05	0.00017	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.52e-05	0.000169	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.48e-05	0.000165	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	1.48e-05	0.000164	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.47e-05	0.000163	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.47e-05	0.000163	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.46e-05	0.000162	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.42e-05	0.000158	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.42e-05	0.000158	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.4e-05	0.000155	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.4e-05	0.000155	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.39e-05	0.000154	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	1.36e-05	0.00015	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	1.35e-05	0.000149	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.31e-05	0.000145	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.27e-05	0.000141	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.24e-05	0.000138	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	1.21e-05	0.000134	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	1.2e-05	0.000133	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.2e-05	0.000133	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.2e-05	0.000133	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.19e-05	0.000131	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.18e-05	0.000131	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.18e-05	0.000131	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.17e-05	0.00013	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.17e-05	0.000129	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.11e-05	0.000123	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.11e-05	0.000123	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.1e-05	0.000122	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.1e-05	0.000122	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.1e-05	0.000122	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.06e-05	0.000118	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.61e-06	0.000107	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	9.43e-06	0.000105	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.37e-06	0.000104	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.15e-06	0.000101	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.08e-06	0.000101	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	8.52e-06	9.44e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.43e-06	8.23e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.28e-06	8.07e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.23e-06	8.02e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	6.87e-06	7.62e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	6.73e-06	7.46e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.72e-06	7.45e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	6.72e-06	7.45e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	6.35e-06	7.03e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	5.82e-06	6.45e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	5.19e-06	5.76e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	5.07e-06	5.62e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.78e-06	5.29e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	4.73e-06	5.25e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.05e-06	4.49e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.12e-06	3.46e-05	CbGpPWpGaD
